The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study

Background: Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, and in over 80% of cases, antibodies are identified against the nicotinic type of acetylcholine receptor (AChR) on the muscle endplate. Despite the availability of various treatment options, patients wi...

Full description

Bibliographic Details
Published in:	Annals of Indian Academy of Neurology
Main Authors:	Pawan T Ojha, Abhijeet M Gaikwad, Rakesh Singh, Kamlesh Jagiasi, Shashank Nagendra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Subjects:	achr positive myasthenia gravis (mg) rituximab treatment refractory
Online Access:	http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=4;spage=395;epage=400;aulast=Ojha

Similar Items

Efficiency of cell-based assays in detecting AChR antibodies in myasthenia gravis sera with low antibody concentrations as determined by radioimmunoprecipitation assay
by: John S. Tzartos, et al.
Published: (2025-05-01)

Rituximab treatment in myasthenia gravis
by: Ana Vesperinas-Castro, et al.
Published: (2023-10-01)

Rituximab in Refractory Myasthenia Gravis – Challenges and Lessons Learnt
by: Karthika A Valaparambil, et al.
Published: (2024-12-01)

Positive experience of the usage of Rituximab in management of refractory myasthenia gravis in Russia
by: N. I. Shcherbakova, et al.
Published: (2015-09-01)

Myasthenia gravis with tongue muscle atrophy: A case series
by: Xue-Lu Zhao, et al.
Published: (2024-05-01)

Role of complement in myasthenia gravis
by: Pyae Phyo San, et al.
Published: (2023-10-01)

Inflammation and autoimmune myasthenia gravis
by: Ruksana Huda
Published: (2023-01-01)

Real world study in Italian public hospital with Efgartigimod in patients affected by generalized myasthenia gravis: influence of clinical and serological factors
by: Manlio Sgarzi, et al.
Published: (2025-05-01)

Serum cytokine profiles in patients with myasthenia gravis
by: Xuan Wu, et al.
Published: (2025-07-01)

Serum interleukin-40 increases in anti-AchR antibody-positive myasthenia gravis and correlates with disease activity
by: Kun Jia, et al.
Published: (2025-09-01)

Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients
by: Eleonora Lekova, et al.
Published: (2022-09-01)

Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
by: Vincenzo Di Stefano, et al.
Published: (2022-10-01)

Safety profile and efficacy of secukinumab in the treatment of autoimmune myasthenia gravis: a single-center retrospective study
by: Shuangmei Zhang, et al.
Published: (2025-10-01)

Antibodies to autoantigen targets in myasthenia and their value in clinical practice
by: S. I. Dedaev
Published: (2015-02-01)

Novel Immunotherapies for Myasthenia Gravis
by: Nair SS, et al.
Published: (2023-04-01)

Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]
by: Waheed W, et al.
Published: (2022-08-01)

Risk factors for generalization of ocular myasthenia gravis
by: Ivana S Djordjevic, et al.
Published: (2025-10-01)

Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy
by: Long He, et al.
Published: (2024-04-01)

Therapeutic Plasma Exchange in AChR-Ab Positive Generalized Myasthenia Gravis: A Real World Study About Its Early Response
by: Chen J, et al.
Published: (2024-04-01)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
by: Antonino Lupica, et al.
Published: (2022-04-01)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01)

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?
by: Jingru Ren, et al.
Published: (2023-05-01)

Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients
by: Marina Mané-Damas, et al.
Published: (2025-05-01)

Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report
by: Bedriye Karaman, et al.
Published: (2025-10-01)

Interleukin-27 levels in patients with myasthenia gravis
by: Liu Xiao-Jiao, et al.
Published: (2020-09-01)

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases
by: Tianying Ma, et al.
Published: (2025-01-01)

Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients
by: Oana Antonia Mihalache, et al.
Published: (2023-12-01)

Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis
by: Siripong Chayanopparat, et al.
Published: (2025-02-01)

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
by: Tuan Vu, et al.
Published: (2023-06-01)

Ocular myasthenia gravis management
by: Mark J. Kupersmith, et al.
Published: (2025-11-01)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
by: Courtney Townsel, et al.
Published: (2016-03-01)

MODERN VIEW OF DIAGNOSIS AND TREATMENT OF MYASTHENIA GRAVIS. CASE REPORT
by: Tatiana V. Chernii, et al.
Published: (2024-06-01)

Single‐cell atlas reveals heterogeneous response to FcRn blockade in anti‐AChR antibody‐positive generalised myasthenia gravis
by: Hui‐Ning Li, et al.
Published: (2025-08-01)

Case Report: Telitacicept in severe myasthenia gravis: a case study with multiple autoantibodies
by: Qian Guo, et al.
Published: (2023-12-01)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
by: Inga Koneczny, et al.
Published: (2019-07-01)

Delayed diagnosis of distal myasthenia gravis: a case report
by: M. L. Cao, et al.
Published: (2024-11-01)

Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review
by: Yue-liang Zheng, et al.
Published: (2025-04-01)

Fetal Surveillance in Pregnancies with Myasthenia Gravis
by: Brîndușa Ana Cimpoca-Raptis, et al.
Published: (2021-11-01)

Pediatric ocular myasthenia gravis: Case report and literature review
by: Adriana Solano, et al.
Published: (2019-01-01)

Editorial: New perspectives in the treatment of myasthenia gravis
by: Elena Cortés-Vicente, et al.
Published: (2024-06-01)